Get the Stockscreener App
168.51
3.05%
-5.30
After Hours:
168.47
-0.04
-0.02%
Natera Inc stock is traded at $168.51, with a volume of 853.01K.
It is down -3.05% in the last 24 hours and up +5.44% over the past month.
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
See More
Previous Close:
$173.81
Open:
$172.64
24h Volume:
853.01K
Relative Volume:
0.66
Market Cap:
$23.13B
Revenue:
$1.96B
Net Income/Loss:
$-253.24M
P/E Ratio:
-88.23
EPS:
-1.91
Net Cash Flow:
$94.06M
1W Performance:
+0.29%
1M Performance:
+5.44%
6M Performance:
+16.62%
1Y Performance:
+34.68%
1-Day Range:
$167.59
$172.64
1-Week Range:
$165.41
$176.82
52-Week Range:
$117.27
$183.00
Natera Inc Stock (NTRA) Company Profile
Name
Natera Inc
Sector
Industry
Phone
650-249-9090
Address
13011 MCCALLEN PASS, AUSTIN, CA
Compare NTRA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
168.51 | 23.30B | 1.96B | -253.24M | 94.06M | -1.91 |
|
TMO
Thermo Fisher Scientific Inc
|
479.46 | 179.95B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
190.05 | 137.90B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
641.14 | 51.04B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
123.24 | 35.19B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
187.22 | 31.26B | 15.70B | 1.24B | 2.01B | 6.91 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-13-25 | Initiated | RBC Capital Mkts | Outperform |
| Jan-23-25 | Initiated | Barclays | Overweight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Apr-08-24 | Resumed | Craig Hallum | Buy |
| Feb-20-24 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-29-23 | Reiterated | BTIG Research | Buy |
| Dec-14-23 | Initiated | Guggenheim | Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Nov-13-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-05-23 | Resumed | JP Morgan | Overweight |
| May-05-23 | Initiated | UBS | Buy |
| Jan-18-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Apr-25-22 | Initiated | Stephens | Overweight |
| Mar-08-22 | Initiated | Goldman | Buy |
| Jan-06-22 | Resumed | Piper Sandler | Overweight |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jun-15-21 | Initiated | Raymond James | Mkt Perform |
| May-25-21 | Initiated | Wells Fargo | Overweight |
| Jan-28-21 | Initiated | Truist | Buy |
| Oct-08-20 | Initiated | BTIG Research | Buy |
| Sep-28-20 | Initiated | Morgan Stanley | Overweight |
| Sep-17-20 | Initiated | SVB Leerink | Outperform |
| Jun-10-20 | Resumed | Piper Sandler | Overweight |
| May-07-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Oct-05-18 | Initiated | JP Morgan | Neutral |
| Jul-05-18 | Reiterated | Piper Jaffray | Overweight |
| Aug-07-17 | Reiterated | Morgan Stanley | Overweight |
| Nov-10-16 | Reiterated | The Benchmark Company | Buy |
| May-23-16 | Reiterated | The Benchmark Company | Buy |
| May-11-16 | Reiterated | The Benchmark Company | Buy |
| Apr-19-16 | Initiated | The Benchmark Company | Buy |
| Sep-28-15 | Upgrade | Wedbush | Neutral → Outperform |
| Aug-14-15 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-04-15 | Initiated | Robert W. Baird | Outperform |
| Jul-27-15 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-27-15 | Initiated | Piper Jaffray | Overweight |
| Jul-27-15 | Initiated | Wedbush | Neutral |
View All
Natera Inc Stock (NTRA) Latest News
Natera, Inc. $NTRA Shares Sold by Cubist Systematic Strategies LLC - MarketBeat
Nissay Asset Management Corp Japan ADV Makes New Investment in Natera, Inc. $NTRA - MarketBeat
Jacobs Levy Equity Management Inc. Acquires New Shares in Natera, Inc. $NTRA - MarketBeat
Why Natera (NTRA) Stock Is Trading Lower Today - FinancialContent
Capital Impact Advisors LLC Acquires Shares of 47,281 Natera, Inc. $NTRA - MarketBeat
Natera, Inc. $NTRA Position Increased by PointState Capital LP - MarketBeat
Millennium Management LLC Sells 129,561 Shares of Natera, Inc. $NTRA - MarketBeat
Natera, Inc. $NTRA Shares Bought by Amundi - MarketBeat
Royal Bank of Canada Buys 10,895 Shares of Natera, Inc. $NTRA - MarketBeat
Natera, Inc. $NTRA Shares Bought by Focus Partners Advisor Solutions LLC - MarketBeat
Discover September 2025's Stocks That May Be Trading Below Estimated Value - simplywall.st
Natera, Inc. $NTRA Shares Sold by Exome Asset Management LLC - MarketBeat
Natera, Inc. (NASDAQ:NTRA) Receives $194.00 Consensus Target Price from Analysts - MarketBeat
Graham Capital Management L.P. Acquires 2,733 Shares of Natera, Inc. $NTRA - MarketBeat
Gotham Asset Management LLC Acquires 5,099 Shares of Natera, Inc. $NTRA - MarketBeat
Samlyn Capital LLC Sells 227,784 Shares of Natera, Inc. $NTRA - MarketBeat
Why Natera (NTRA) Shares Are Falling Today - Yahoo Finance
Natera, Inc. $NTRA is Fred Alger Management LLC's 10th Largest Position - MarketBeat
Guardant Health gains amid $292.5M verdict against Natera over false advertising claims (update) - MSN
Natera at Baird Global Healthcare Conference: Strategic Growth Insights - Investing.com
Scientech Research LLC Makes New Investment in Natera, Inc. $NTRA - MarketBeat
Insider Selling: Natera (NASDAQ:NTRA) CEO Sells 5,079 Shares of Stock - MarketBeat
Transcript : Natera, Inc. Presents at Baird Global Healthcare Conference 2025, Sep-09-2025 08 - MarketScreener
Asia-Pacific Non-Invasive Prenatal Testing Market Growth - GlobeNewswire
Europe Non-Invasive Prenatal Testing Market Growth and - GlobeNewswire
Europe Non-Invasive Prenatal Testing Market Growth and Company Analysis Report 2025-2033 Featuring Eurofins Scientific, F. Hoffmann-La Roche, Invitae, Illumina, Natera, Centogene, and Qiagen - Yahoo Finance
Asia-Pacific Non-Invasive Prenatal Testing Market Growth and Company Analysis Report 2025-2033 Featuring Eurofins Scientific, F. Hoffmann-La Roche, Invitae, Illumina, Natera, Centogene, and Qiagen - uk.finance.yahoo.com
Natera, Inc. $NTRA Shares Sold by Granahan Investment Management LLC - MarketBeat
Cinctive Capital Management LP Takes $3.01 Million Position in Natera, Inc. $NTRA - MarketBeat
3 Reasons We’re Fans of Natera (NTRA) - Yahoo Finance
Natera (NASDAQ:NTRA) Stock Acquired Rep. Josh Gottheimer - MarketBeat
EFG Asset Management North America Corp. Sells 8,563 Shares of Natera, Inc. $NTRA - MarketBeat
NWI Management LP Boosts Stock Holdings in Natera, Inc. $NTRA - MarketBeat
A Fresh Look at Natera (NTRA) Valuation After Launch of ARCHER Phase III Bladder Cancer Trial - simplywall.st
Natera at Morgan Stanley Conference: Strategic Growth in Healthcare - Investing.com
Natera at Morgan Stanley Conference: Strategic Growth in Healthcare By Investing.com - Investing.com South Africa
Can Natera Inc. Escape Recent Bear ChannelSwing Trade & Weekly Breakout Stock Alerts - beatles.ru
Natera (NTRA): How the ARCHER Trial May Shape Future Valuation After Key Signatera Milestone - Yahoo Finance
Natera Stock (NTRA) Opinions on AI Platform Launch and Insider Sales - Quiver Quantitative
Published on: 2025-09-08 15:18:25 - beatles.ru
Polar Asset Management Partners Inc. Decreases Stock Position in Natera, Inc. $NTRA - MarketBeat
Panagora Asset Management Inc. Boosts Position in Natera, Inc. $NTRA - MarketBeat
ADAR1 Capital Management LLC Takes Position in Natera, Inc. $NTRA - MarketBeat
Natera, Inc. $NTRA Shares Sold by Kestra Advisory Services LLC - MarketBeat
Insider Selling: Natera (NASDAQ:NTRA) Director Sells 2,750 Shares of Stock - MarketBeat
Earnings Miss: What are Natera Inc.’s technical support levels2025 Geopolitical Influence & Verified Short-Term Plans - خودرو بانک
Natera Inc: President Moshkevich sells $499,864 in stock - Investing.com India
What’s the MACD signal for Natera Inc.2025 Short Interest & Technical Confirmation Alerts - 더경남뉴스
Natera Inc: President Moshkevich sells $499,864 in stock By Investing.com - Investing.com Canada
Natera CEO Chapman sells $845k in shares By Investing.com - Investing.com Australia
Subdued Growth No Barrier To Natera, Inc.'s (NASDAQ:NTRA) Price - 富途牛牛
Natera Inc Stock (NTRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):